Consolidated Condensed Statement of Operations (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|||||||
| Income Statement [Abstract] | ||||||||||
| Revenues | $ 13,903,032 | $ 2,134,588 | [1],[2] | $ 38,721,336 | [1],[2] | $ 6,300,857 | ||||
| Cost of goods sold | 8,986,728 | 1,294,200 | 25,348,791 | 4,168,984 | ||||||
| Gross Margin | 4,916,304 | 840,388 | 13,372,545 | 2,131,873 | ||||||
| Operating Expenses | ||||||||||
| Operations | 2,012,744 | 636,705 | 5,380,364 | 1,343,584 | ||||||
| Research and development | 350,548 | 39,369 | 994,649 | 110,002 | ||||||
| Sales and marketing | 613,614 | 373,539 | 1,983,665 | 883,513 | ||||||
| General and administrative | 10,238,161 | 4,730,063 | 28,265,622 | 15,151,160 | ||||||
| Depreciation and amortization | 64,859 | 22,449 | 204,996 | 63,635 | ||||||
| Total operating expenses | 13,279,926 | 5,802,125 | 36,829,296 | 17,551,894 | ||||||
| Loss from operations | (8,363,622) | (4,961,737) | (23,456,751) | (15,420,021) | ||||||
| Other income and (expense) | ||||||||||
| Interest income | 1,700,977 | 715,489 | 4,313,216 | 942,755 | ||||||
| Unrealized gain (loss) from investments | (18,381,680) | 5,849,713 | (12,773,139) | 5,849,713 | ||||||
| Realized gain from investments | 0 | 0 | 9,532,673 | 0 | ||||||
| Change in contingent consideration for Rotor Lab | 0 | 0 | (153,000) | 0 | ||||||
| Loss from foreign currency transactions | (622) | 0 | (7,858) | 0 | ||||||
| Interest expense | 0 | 0 | (648) | 0 | ||||||
| Other income, net | (16,681,325) | 6,565,202 | 911,244 | 6,792,468 | ||||||
| Net income (loss) | (25,044,947) | 1,603,465 | (22,545,507) | (8,627,553) | ||||||
| STATEMENT OF COMPREHENSIVE INCOME (LOSS) | ||||||||||
| Net income (loss) | (25,044,947) | 1,603,465 | (22,545,507) | (8,627,553) | ||||||
| Foreign currency translation adjustment | (10,397) | 0 | 24,348 | 0 | ||||||
| Comprehensive income (loss) | $ (25,055,344) | $ 1,603,465 | $ (22,521,159) | $ (8,627,553) | ||||||
| Net income (loss) per share | ||||||||||
| Basic | $ (0.50) | $ 0.05 | $ (0.49) | $ (0.38) | ||||||
| Diluted | $ (0.50) | $ 0.05 | $ (0.49) | $ (0.38) | ||||||
| Weighted average common shares outstanding | ||||||||||
| Basic | 49,968,207 | 30,002,179 | 46,094,557 | 22,610,516 | ||||||
| Diluted | 49,968,207 | 30,581,194 | 46,094,557 | 22,610,516 | ||||||
| ||||||||||
| X | ||||||||||
- Definition Amount of increase (decrease) in value of liability in contingent consideration arrangement in business combination, including, but not limited to, difference arising upon settlement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). No definition available.
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of realized gain (loss) on investment. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition Amount of unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|